Indeed, SS patients presenting autoantibodies against the extracellular domain of AQP8 and AQP9 (detected with a higher frequency—39%) or against AQP1 and AQP3 (detected at lower frequency) displays more severe xerophthalmia as compared to control individuals [86]. Here, AQP1 is linked to synovial sarcoma.